These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2040182)
1. Renal function of pre-dialysis patients during treatment with recombinant human erythropoietin. Koene RA; Frenken LA Contrib Nephrol; 1991; 88():192-9; discussion 200. PubMed ID: 2040182 [No Abstract] [Full Text] [Related]
2. rHuEpo before dialysis and in dialysed patients. López-Gómez JM; Jofre R; Moreno F; Verde E; Valderràbano F Nephrol Dial Transplant; 1995; 10 Suppl 6():31-5. PubMed ID: 8524491 [No Abstract] [Full Text] [Related]
3. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications]. Romero González R; Torquet Escuder P Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205 [No Abstract] [Full Text] [Related]
4. Effect of recombinant human erythropoietin on the anemia of chronic renal failure. Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients. Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis. Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin for anemia. Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624 [No Abstract] [Full Text] [Related]
8. Erythropoietin. Beresford CH N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007 [No Abstract] [Full Text] [Related]
9. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease. Koene RA; Frenken LA Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365 [No Abstract] [Full Text] [Related]
10. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]
11. Hypertension as a possible complication of recombinant human erythropoietin therapy. Brunkhorst R; Nonnast-Daniel B; Koch KM; Frei U Contrib Nephrol; 1991; 88():118-25; discussion 126. PubMed ID: 2040173 [TBL] [Abstract][Full Text] [Related]
12. Management of blood pressure changes during recombinant human erythropoietin therapy. Levin N Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081 [TBL] [Abstract][Full Text] [Related]
13. Effects of erythropoietin in predialysis patients. Anderson S Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665 [No Abstract] [Full Text] [Related]
14. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin. Baldamus CA; Steffen AM; Brunner R; Pollok M Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531 [No Abstract] [Full Text] [Related]
15. Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients. Onoyama K; Kumagai H; Takeda K; Shimamatsu K; Fujishima M Nephrol Dial Transplant; 1989; 4(11):966-70. PubMed ID: 2516888 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials. Sobota JT Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519 [No Abstract] [Full Text] [Related] [Next] [New Search]